CA2005358A1 - Somatotropin analogs - Google Patents

Somatotropin analogs

Info

Publication number
CA2005358A1
CA2005358A1 CA002005358A CA2005358A CA2005358A1 CA 2005358 A1 CA2005358 A1 CA 2005358A1 CA 002005358 A CA002005358 A CA 002005358A CA 2005358 A CA2005358 A CA 2005358A CA 2005358 A1 CA2005358 A1 CA 2005358A1
Authority
CA
Canada
Prior art keywords
rbst
somatotropin
animal
serine
asparagine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002005358A
Other languages
English (en)
French (fr)
Inventor
Robert L. Garlick
Stephen B. Lyle
John E. Mott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CA2005358A1 publication Critical patent/CA2005358A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002005358A 1989-01-19 1989-12-13 Somatotropin analogs Abandoned CA2005358A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29910789A 1989-01-19 1989-01-19
US07/299,107 1989-01-19

Publications (1)

Publication Number Publication Date
CA2005358A1 true CA2005358A1 (en) 1990-07-19

Family

ID=23153338

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002005358A Abandoned CA2005358A1 (en) 1989-01-19 1989-12-13 Somatotropin analogs

Country Status (7)

Country Link
EP (1) EP0454730A1 (da)
JP (1) JPH04502762A (da)
KR (1) KR910700264A (da)
AU (1) AU634517B2 (da)
CA (1) CA2005358A1 (da)
DK (1) DK136991D0 (da)
WO (1) WO1990008164A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355460B1 (en) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
ZA936811B (en) * 1992-10-28 1995-03-15 Upjohn Co Somatotropin modifications
US7795210B2 (en) 2001-10-10 2010-09-14 Novo Nordisk A/S Protein remodeling methods and proteins/peptides produced by the methods
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7696163B2 (en) 2001-10-10 2010-04-13 Novo Nordisk A/S Erythropoietin: remodeling and glycoconjugation of erythropoietin
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
KR20060003862A (ko) 2003-03-14 2006-01-11 네오스 테크놀로지스, 인크. 수용성분기폴리머 및 그 접합체
MXPA05010773A (es) 2003-04-09 2005-12-12 Neose Technologies Inc Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos.
EP1624847B1 (en) * 2003-05-09 2012-01-04 BioGeneriX AG Compositions and methods for the preparation of human growth hormone glycosylation mutants
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US7842661B2 (en) 2003-11-24 2010-11-30 Novo Nordisk A/S Glycopegylated erythropoietin formulations
US7956032B2 (en) 2003-12-03 2011-06-07 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
BRPI0506741A (pt) 2004-01-08 2007-05-15 Neose Technologies Inc glicosilação de peptìdeos ligados a o
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
US8268967B2 (en) 2004-09-10 2012-09-18 Novo Nordisk A/S Glycopegylated interferon α
JP5948627B2 (ja) 2004-10-29 2016-07-20 レイショファーム ゲーエムベーハー 線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化
EP1858543B1 (en) 2005-01-10 2013-11-27 BioGeneriX AG Glycopegylated granulocyte colony stimulating factor
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
RS52845B (en) 2007-04-03 2013-12-31 Biogenerix Ag TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF
US9493499B2 (en) 2007-06-12 2016-11-15 Novo Nordisk A/S Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
EP2257311B1 (en) 2008-02-27 2014-04-16 Novo Nordisk A/S Conjugated factor viii molecules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201918A (en) * 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
WO1987001708A2 (en) * 1985-09-18 1987-03-26 The Upjohn Company Enhanced bioactivity of mammalian somatotropin through selective deamidation
US5104806A (en) * 1987-03-12 1992-04-14 Amgen, Inc. Porcine growth hormone analogs encoding dna

Also Published As

Publication number Publication date
KR910700264A (ko) 1991-03-14
WO1990008164A1 (en) 1990-07-26
AU4942790A (en) 1990-08-13
DK136991A (da) 1991-07-17
DK136991D0 (da) 1991-07-17
EP0454730A1 (en) 1991-11-06
JPH04502762A (ja) 1992-05-21
AU634517B2 (en) 1993-02-25

Similar Documents

Publication Publication Date Title
AU634517B2 (en) Somatotropin analogs
FI113372B (fi) Menetelmä LIF-polypeptidin (LIF = Leukemiaa estävä tekijä) valmistamiseksi
US5155214A (en) Basic fibroblast growth factor
AU620673B2 (en) Somatotropin analogs
CA1340455C (en) Human preproinsulin-like growth factor i
GB2147902A (en) Microbially produced bgh and its use
SK171492A3 (en) Polypeptide, method of its preparation its use and pharmaceutical agent
EP0111389A2 (en) Substantially pure porcine growth hormone, DNA sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone
US5464774A (en) Bovine basic fibroblast growth factor
Keshet et al. Cloning of bovine growth hormone gene and its expression in bacteria
FI81378B (fi) Dna som kodar foer en prekursor till hpgrf, expressionsvektor och foerfarande foer expression av en prekursor till hpgrf.
AU639245B2 (en) Somatotropin analogs
US5631227A (en) Somatotropin analogs
US5070075A (en) Human preproinsulin-like growth factor I
EP0282319B1 (en) Porcine growth hormone analogs
EP0236452B1 (en) Enhanced bioactivity of mammalian somatotropin through selective deamidation
EP0303858A2 (en) Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor
US5663305A (en) Somatotropin analogs
EP0263206B1 (en) Enhanced bioactivity of mammalian somatotropin through selective deamidation
KR0121322B1 (ko) 백혈병 억제 인자 제조를 위한 재조합 dna 분자 및 숙주 세포
HU204889B (en) Process for producing erythropoietin

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead